References
- Lynn M, Jeroukhimov I, Klein Y, et al. Updates in the management of severe coagulopathy in trauma patients. Int Care Med. 2002;28:S241–S247.
- Hoyt DB, Bulger EM, Knudson MM. Death in the operating room: an analysis of a multi-center experience. J Trauma. 1994;37:426–432.
- Moore FA, Nelson T, McKinley BA, et al. Massive transfusion in trauma patients: tissue hemoglobin oxygen saturation predicts poor outcomes. J Trauma. 2008;64:1010–1023.
- Shaz BH, Dente CJ, Harris RS, et al. Transfusion management of trauma patients. Anesth Analg. 2009;108:1760–1768.
- Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248:447–458.
- Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth. 2005;95:130–139.
- Razynska A, Bucci E. Zero-link polymerization: a new class of polymeric hemoglobins. In: Tsuchida E, editor. Blood substitutes: present and future perspectives. Lausanne (Switzerland): Elsevier; 1998. p. 265–279.
- Harrington JP, Wollocko H. Molecular design properties of OxyVita hemoglobin, a new generation therapeutic oxygen carrier: a review. J Funct Biomater. 2011;2:414–424.
- Jahr JS, Weeks DL, Desai P, et al. Does OxyVita, a new-generation hemoglobin-based oxygen carrier, or Oxyglobin acutely interfere with coagulation compared with normal saline or 6% hetastarch? An ex vivo thromboelastography study. J Cardiothorac Vasc Anesth. 2008;22:34–39.
- Reynolds PS, Barbee RW, Skaflen MD, et al. Low-volume resuscitation cocktail extends survival after severe hemorrhagic shock. Shock. 2007;28:45–52.
- Harrington JP, Wollocko H, Wollocko A, et al. Next generation hemoglobin based oxygen carrier, OxyVita C, with coagulation capacity using a modified lyophilization process: protection of components [Internet]. 3542-Pos B697, 29 January 2013. [cited 2013 Feb 06] Available from: http://doi.org/10.1016/j.bpj.2012.11.3803
- Harringrton1 JP, Wollocko J, Kostecki E, et al. Development of a multifunctional resuscitation fluid (MRF) incorporating coagulation components (Resusix™), (Stasix.) with a new generation hemoglobin‐based‐oxygen carrier (OxyVita®C): initial compatibility studies. Combat Casualty Care Research Program, U.S. Army Medical Research and Material Command Conference, August 2012.
- Matheson B, Kwansa HE, Bucci E, et al. Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol. 2002;93:1479–1486.
- Rebel A, Ulatowski JA, Kwansa H, et al. Cerebrovascular response to decreased hematocrit: effect of cell free hemoglobin, plasma viscosity, and CO2. Am J Physiol Heart Circ Physiol. 2003;285:1600–1608.
- Mito T, Nemoto M, Kwansa H, et al. Decreased damage from transient focal cerebral ischemia by transfusion of zero-linked hemoglobin polymers in mouse. Stroke. 2009;40:278–284.